189 Epizód

  1. Targeting FGFR in Urothelial Cancer and Beyond

    Közzétéve: 2021. 03. 23.

  2. Expert Answers to HCP Questions on Pancreatic Cancer Treatment

    Közzétéve: 2021. 03. 22.

  3. Expert Answers to HCP Questions on CAR T-Cell Therapies in Lymphoma

    Közzétéve: 2021. 03. 18.

  4. Frequently Asked Questions on Emerging Antibody–Drug Conjugates in the Treatment of Advanced Non-Small-Cell Lung Cancer

    Közzétéve: 2021. 03. 17.

  5. Expert Answers to HCP Questions on CAR T-Cell Therapies in Myeloma and Management of Key Toxicities

    Közzétéve: 2021. 03. 12.

  6. Expert Insights on Highlights From ASH 2020 on Multiple Myeloma

    Közzétéve: 2021. 03. 12.

  7. Expert Insights on Key Data From ASH 2020 on Acute and Chronic Leukemias

    Közzétéve: 2021. 02. 26.

  8. Expert Insight on Key Data From WCLC 2020 in Early-Stage Lung Cancer

    Közzétéve: 2021. 02. 24.

  9. Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Argentina

    Közzétéve: 2021. 02. 22.

  10. Expert Insights on Key Data From ASH 2020 on Nonmalignant Hematologic Disorders

    Közzétéve: 2021. 02. 10.

  11. Expert Insights on Key Data From ASH 2020 on Myelodysplastic Syndromes and Myeloproliferative Neoplasms

    Közzétéve: 2021. 02. 05.

  12. Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Italy

    Közzétéve: 2021. 02. 04.

  13. Expert Answers to Questions on Contemporary Management of Hemophilia A

    Közzétéve: 2021. 02. 04.

  14. Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From the United States

    Közzétéve: 2021. 02. 01.

  15. An Expert Overview of Immunotherapy for Advanced HCC

    Közzétéve: 2021. 01. 19.

  16. Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Spain

    Közzétéve: 2021. 01. 08.

  17. Expert Answers to Pathologist Questions on New Biomarkers for Precision Therapy in Lung Cance

    Közzétéve: 2020. 12. 28.

  18. Application of Individualized Treatment for CLL/SLL: Novel Agents, Combinations, and Sequencing Therapy: FAQ

    Közzétéve: 2020. 12. 24.

  19. Practical Insights on Key Data From ESMO 2020 Informing Precision Medicine in NSCLC

    Közzétéve: 2020. 12. 21.

  20. Immunotherapy for Advanced HCC: Experts Answer Clinician Questions

    Közzétéve: 2020. 12. 17.

8 / 10

Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.

Visit the podcast's native language site